Harbour Investments, Inc. Glaukos Corp Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$40.27 - $56.99 $21,624 - $30,603	-537 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $284 - $505	-6 Reduced 1.1%	537 $26,000
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $7,379 - $9,867	-101 Reduced 15.68%	543 $46,000
Q1 2021 Aug 17, 2021	BUY	$70.43 - $97.42 $45,356 - $62,738	644 New	644 $54,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.